[2012]

Lucke-Wold BP, Turner RC, Lucke-Wold AN, Rosen CL, Huber JD. Age and the
metabolic syndrome as risk factors for ischemic stroke: improving preclinical models of
ischemic stroke. Yale J Biol Med (2012 Dec) 85(4): 523-39.

Turner RC, Naser ZJ, Bailes JE, Smith DW, Fisher JA, Rosen CL. Effect of slosh
mitigation on histologic markers of traumatic brain injury: laboratory investigation. J
Neurosurg (2012 Dec) 117(6): 1110-8.

Turner RC, Seminerio MJ, Naser ZJ, Ford JN, Martin SJ, Matsumoto RR, Rosen CL,
Huber JD. Effects of aging on behavioral assessment performance: implications for
clinically relevant models of neurological disease. J Neurosurg (2012 Sep) 117(3): 62937.

Leon RL, Li X, Huber JD, Rosen CL. Worsened outcome from middle cerebral artery
occlusion in aged rats receiving 17Β-estradiol. Endocrinology (2012 Jul) 153(7): 338693.

Popa-Wagner A, Buga AM, Turner RC, Rosen CL, Toescu E. Cerebrovascular disorders:
role of aging. J Aging Res (2012) 2012:128146.

VanGilder RL, Huber JD, Rosen CL, Barr TL. The transcriptome of cerebral ischemia.
Brain Res Bull (2012 Jul) 88(4): 313-9.
[2011]

Rosen CL, Steinberg GK, DeMonte F, Delashaw JB Jr, Lewis SB, Shaffrey ME, Aziz K,
Hantel J, Marciano FF. Results of the prospective, randomized, multicenter clinical trial
evaluating a biosynthesized cellulose graft for repair of dural defects. Neurosurgery
(2011 Nov) 69(5): 1093-103.

Leon RL, Huber JD, Rosen CL. Potential age-dependent effects of estrogen on neural
injury. Am J Pathol (2011 Jun) 178(6): 2450-60.

Turner RC, Dodson SC, Rosen CL. Medical management of cerebellar abscess: a case
report and review of the literature. WV Med J (2011 Mar-Apr) 107(2): 21-3.

VanGilder RL, Rosen CL, Barr TL, Huber JD. Targeting the neurovascular unit for
treatment of neurological disorders. Pharmacol Ther (2011 Jun) 130(3): 239-47.

Sivak-Callcott JA, Diaz SR, Ducatman AM, Rosen CL, Nimbarte AD, Sedgeman JA. A
Survey Study of Occupational Pain and Injury in Ophthalmic Plastic Surgeons. Ophthal
Plast Reconstr Surg. (2011 Jan - Feb), 27(1):28-32.
[2010]


Vangilder RL, Rosen CL, Barr TL, Huber JD. Targeting the neurovascular unit for
treatment of neurological disorders. Pharmacol Ther. (2010) Epub.
Dinapoli VA, Benkovic SA, Li X, Kelly KA, Miller DB, Rosen CL, Huber JD,
O'Callaghan JP. Age exaggerates proinflammatory cytokine signaling and truncates
signal transducers and activators of transcription 3 signaling following ischemic stroke in
the rat. Neuroscience (2010) 170(2):633-44.
[2009]


[2008]
Tan Z, Li X, Kelly KA, Rosen CL, Huber JD. Plasminogen activator inhibitor type 1
derived peptide, EEIIMD, diminishes cortical infarct but fails to improve neurological
function in aged rats following middle cerebral artery occlusion. Brain Res
(2009),1281:84-90.
Kelly KA, Li X, Tan Z, VanGilder RL, Rosen CL, Huber JD. NOX2 inhibition with
apocynin worsens stroke outcome in aged rats. Brain Res (2009), 1292:165-72.




DiNapoli VA, Huber JD, Houser K, Li X, Rosen CL. Early disrutpions of the blood-brain
barrier may contribute to exacerbated neuronal damage and prolonged functional
recovery following stroke in aged rats. Neurobiology and Aging (2008), 29(5):753-764.
Miele VJ, France JC, Rosen CL. Subaxial positional vertebral artery occlusion corrected
by decompression and fusion. Spine (2008), 15;33(11):E366-370.
Rosen CL, Orphanos J, Marano G, Nugent RG. "The use of MR-Myelography
combining flexion and extension imaging in the diagnosis of cervical myelopathy: a case
report." West Virginia Medical Journal (2008, in press).
Rosen CL, Sedney C, Sivak J. "Single-stage complex reconstruction for fibrous
dysplasia: a case report." Skull Base (2008), 18(4):275-279.